Adverse event profile is still unknown. Studies are ongoing [68]. Other MEK inhibitors caused cardiac and ophthalmologic side effects, rash, diarrhea, peripheral edema, fatigue, and dermatitis acneiform [68]. This evidence concerns the gene MAP2K7 and skin disorder.